Personalis reported Q2 2025 financial results with revenue falling 24% year-over-year to $17.2 million, missing estimates. Despite financial challenges, the company saw a 59% increase in clinical test volumes for its NeXT Personal platform, with promising cancer detection research.

AI is transforming healthcare with projected market growth exceeding $110 billion by 2030, enabling advanced diagnostic tools, early disease detection, and more efficient medical research across multiple sectors.

The global gene panel market is projected to reach $11.75 billion by 2031, growing at a CAGR of 19.30% during the forecast period. The market growth is driven by advancements in genomic research, rising prevalence of genetic disorders, and growing awareness of genetic testing.

Tempus AI, a niche AI company, has increased its stake in Personalis, a biotech firm specializing in cancer diagnostics. The move has led to a significant surge in Tempus AI's stock price, outperforming the broader market.

Personalis (NASDAQ:PSNL) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 0 0 0 0 Last 30D 1 0 0 0 0 1M Ago 2 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Personalis, presenting an average target of $3.62, a high estimate of $4.00, and a low estimate of $3.50. Observing a 57.39% increase, the current average has risen from the previous average price target of $2.30. Decoding Analyst Ratings: A Detailed Look The perception of Personalis by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Mike Matson Needham Maintains Buy $3.50 - Thomas Flaten Lake Street Announces Buy $4.00 - Mike Matson Needham Maintains Buy $3.50 - Mike Matson Needham Raises Buy $3.50 $2.30 Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Personalis. ...Full story available on Benzinga.com

Tesla, Inc. (NASDAQ:TSLA) shares settled lower for a third session on the trot on Tuesday amid worries over a potentially dismal quarter and also rumors of a strategic shift in its product pipeline plans. Undeterred by the predicament, Ark Invest run by Tesla bull Cathie Wood was a buyer of the weakness. What Happened: Ark, through its ARK Innovation ETF (NYSE:ARKK), ARK Autonomous Technology & Robotics ETF (CBOE: ARKQ) and ARK Next Generation Internet ETF (NYSE:ARKW), bought 20,683 shares of Tesla on Monday valued at $3.25 million. The stock settled the session down 2.71% at $157.11, according to Benzinga Pro data. Intraday, the stock dropped as much as 4.8% to a low of $153.75 before recouping some of the losses. Tesla is now the top holding of the firm’s ...Full story available on Benzinga.com

On Wednesday, Cathie Wood’s Ark Invest made a significant move by purchasing additional shares of Pinterest Inc (NYSE:PINS). The PINS Trade Ark Invest’s Fintech Innovation ETF (NYSE:ARKF) acquired 26,925 shares of Pinterest, a popular social media website and a rival of platforms like Meta Platforms-owned Instagram and X. This move comes amidst a mixed financial picture for Pinterest, but with promising user growth as reported in their recent fourth-quarter earnings. The value of this trade, based on the closing price of $35.28 on the same day is $949,914. This isn’t the first time Ark Invest has shown interest in Pinterest. Back in February, the investment firm made headlines when it purchased over $23 million worth of Pinterest shares, demonstrating its confidence in the company’s potential despite the Q4 turbulence. This ...Full story available on Benzinga.com

On Thursday, Cathie Wood-led Ark Invest purchased a substantial number of shares in Tesla Inc. (NASDAQ:TSLA), despite the electric vehicle giant’s recent dip in stock price. The TSLA Trade Ark Invest’s ETFs, ARK Innovation ETF (NYSE:ARKK) and ARK Next Generation Internet ETF (NYSE:ARKW), purchased 65,514 and 14,437 shares of Tesla respectively. This move comes after Tesla’s stock price had tumbled nearly 2.25%. The value of the Tesla shares bought by Ark Invest on Thursday is estimated to be around $14 million, calculated from the closing price of $175.79. This move continues Ark’s trend of increasing its bet on Tesla. Just earlier in the week, Ark had bought Tesla shares worth $28.21 million, as the stock rebounded and outperformed the broader market. Ark Invest’s Tasha Keeney estimated a $28 trillion opportunity in AI’s financial impact, particularly highlighting Tesla and drone technology. Keeney projected a rise in equity ...Full story available on Benzinga.com

On Wednesday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Block Inc (NYSE:SQ) amidst Bitcoin (CRYPTO: BTC) prices recovering. The Block Inc Trade The sale, worth $3.5 million, was executed through Ark's flagship ARK Innovation ETF (NYSE:ARKK) and ARK Next Generation Internet ETF (NYSE:ARKW) with a total of 42,608 shares sold. The value of the trade, calculated from the latest closing price of $81.46. Notably, at the time of writing, Bitcoin traded nearly 6.6% higher at $67,330.71. Ark has sold Block shares in every trading session of the current week. On Monday, Ark sold Block shares worth $8.95 million and on Tuesday, the firm sold $7.5 million worth. For the week, ...Full story available on Benzinga.com

On Tuesday, Cathie Wood-led Ark Invest offloaded a significant amount of Block Inc (NYSE:SQ) shares amidst a downturn in Bitcoin (CRYPTO: BTC) prices. The Block Inc Trade Ark Invest’s decision to sell off Block shares came as a surprise to many, given the company’s strong ties to the cryptocurrency market. The sale was executed through Ark’s flagship ARK Innovation ETF (NYSE:ARKK) and ARK Next Generation Internet ETF (NYSE:ARKW) with a total of 9,437 shares sold. The value of the trade, calculated from the latest closing price of $79.32, amounted to approximately $7.5 million. This is the second such sale of the shares of the Jack Dorsey-led company this week. On Monday, Ark sold $8.95 million worth of Block shares. It should be noted that last ...Full story available on Benzinga.com

On Thursday, Cathie Wood-led Ark Invest made some significant trades, with Coinbase Global Inc (NASDAQ:COIN) and Palantir Technologies Inc (NYSE:PLTR) being the most prominent. The Coinbase Trade Ark Invest sold a substantial number of Coinbase shares across three of its funds: ARK Innovation ETF (NYSE:ARKK), ARK Next Generation Internet ETF (NYSE:ARKW), and Ark Fintech Innovation ETF (NYSE:ARKF). The total number of shares sold was 54,215. The transaction was valued at $13.15 million. This move came as Bitcoin (CRYPTO: BTC) was nearing a new all-time high, flirting with the $69,000 mark. Coinbase shares closed at $242.62, up 1.71% for the day. Trending: Bitcoin To $100,000? Here’s what gold bug Peter Schiff said could happen on Anthony Pompliano’s podcast. The Palantir Trade On the other hand, Ark Invest bought 19,749 shares of Palantir, worth $522,558, for its ARK Space Exploration & Innovation ETF (BATS:ARKX). ...Full story available on Benzinga.com

The Dow Jones index closed lower by over 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Aclaris Therapeutics The Trade: Aclaris Therapeutics, Inc. (NASDAQ: ACRS) Director Andrew Kenneth William Powell acquired a total of 14,500 shares an average price of $1.24. To ...